{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:50:58Z","timestamp":1764161458008,"version":"3.46.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacadv.2025.102074","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T22:49:14Z","timestamp":1755557354000},"page":"102074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Yoshihiro","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6300-9112","authenticated-orcid":false,"given":"Takenobu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9639-5470","authenticated-orcid":false,"given":"Takefumi","family":"Kishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuyuki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-1424","authenticated-orcid":false,"given":"Jumpei","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9901","key":"10.1016\/j.jacadv.2025.102074_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102074_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46324","article-title":"Evaluation of adiposity and cognitive function in adults","volume":"5","author":"Anand","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.jacadv.2025.102074_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102074_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/ajkd.2002.34885","article-title":"The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics","volume":"40","author":"Leskinen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacadv.2025.102074_bib5","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102074_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102074_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2025.102074_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"24","key":"10.1016\/j.jacadv.2025.102074_bib9","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102074_bib10","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.102074_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","volume":"6","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacadv.2025.102074_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1464-5491.1995.tb02055.x","article-title":"Comparing the incidence of lower extremity amputations across the world: the global lower extremity amputation study","volume":"12","author":"Unwin","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacadv.2025.102074_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1365-2168.2000.01344.x","article-title":"Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia","volume":"87","author":"Unwin","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacadv.2025.102074_bib14","article-title":"Major lower limb amputations: recognizing pitfalls","volume":"13","author":"Pran","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jacadv.2025.102074_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejvs.2021.05.025","article-title":"Effects of statin therapy and dose on cardiovascular and limb outcomes in peripheral arterial disease: a systematic review and meta-analysis","volume":"62","author":"Sofat","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacadv.2025.102074_bib16","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/jcm13061670","article-title":"Sodium-glucose cotransporter-2 inhibitors in heart failure with malnutrition, frailty, sarcopenia, or cachexia","volume":"13","author":"Horiuchi","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacadv.2025.102074_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9305","article-title":"Comparative outcomes of empagliflozin to dapagliflozin in patients with heart failure","volume":"7","author":"Modzelewski","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacadv.2025.102074_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"10.1016\/j.jacadv.2025.102074_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.resuscitation.2019.07.002","article-title":"Intra-aortic balloon pump and survival with favorable neurological outcome after out-of-hospital cardiac arrest: a multicenter, prospective propensity score-matched study","volume":"143","author":"Kishimori","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.jacadv.2025.102074_bib20","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2025.102074_bib21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25004995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25004995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:46:38Z","timestamp":1764161198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25004995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2772963X25004995"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102074","relation":{},"ISSN":["2772-963X"],"issn-type":[{"type":"print","value":"2772-963X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102074"}}